A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina
Negri Aranguren, Florencia, Cranco, Santiago, Shanley, Claudia, Fernandez, Isolda I., Prates, Maria Virginia, Otero, Victoria, Fiad, Lorena, Foncuberta, Maria Cecilia, Miodosky, Marcela, Pavlovsky, Miguel A., Kuminsky, Gustavo, Bordone, Javier, Wannesson, Bruno, Corso, Ariel Corso, Riveros, Dardo, Marquez, Marisa, Jarchum, Gustavo, Jarchum, Maria Sol, Cerutti, Ider Ramon, Bistmas, Alicia, Tamashiro, Monica, De Stefano, Giselda, Navieckas, Alicia, Cugliari, Silvana, Negri Aranguren, Pedro, Balaguer, Gabriela, Tosin, Maria, Remaggi, Guillermina, Altuve, Juan, Garcia, Juan Jose, Ferrari, Luciana C., Klein, Graciela, Guanchiale, Luciana, Beligoy, Luis, Marull, Mariana, Dacunto, Maria Cecilia, Zerga, Marta Elisa, Kurgansky, Nicolas Matias, Pujol, Marcelo, Taus, Rossana L., Sackman, Federico, Canosa, Veronica Cintia, Cruset, Soledad, Riddick, Maximiliano, Pavlovsky, Astrid
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article